Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX-100 in early to moderate presbyopia
NCT03201562Phase 2Completed
- Sponsor
- LENZ Therapeutics
- Start
- Apr 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aceclidine + tropicamide in presbyopia, sponsored by LENZ Therapeutics. Started Apr 2017; status: completed.
02
Drugs
aceclidine + tropicamide
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT03201562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03201562.